Cover Image

Direct-to-consumer advertising : marketing, education, or deception? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, May 8, 2008.

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. G.P.O., 2008.
Subjects:	Direct-to-consumer prescription drug advertising > United States. Advertising > Drugs > United States. Drugs > United States > Marketing. Prescription pricing > United States.
Online Access:	Electronic resource (PDF)

Similar Items

Direct-to-consumer advertising : marketing, education, or deception? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, May 8, 2008.
Published: (2008)

The impact of direct-to-consumer drug advertising on seniors' health and health care costs : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, first session, Washington, DC, September 29, 2005.
Published: (2006)

The impact of direct-to-consumer drug advertising on seniors' health and health care costs : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, first session, Washington, DC, September 29, 2005.
Published: (2006)

Prescription drugs : improvements needed in FDA's oversight of direct-to-consumer advertising : report to congressional requesters.
Published: (2006)

Prescription drugs : improvements needed in FDA's oversight of direct-to consumer advertising : report to congressional requesters /
Published: (2006)

Direct to consumer advertising (DTC) : hearing before the Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, first session, July 24, 2001.
Published: (2004)

Direct-to-consumer advertising of prescription drugs : what are the consequences? : hearing before the Special Committee on Aging, United States Senate, One Hundred Eighth Congress, first session, Washington, DC, July 22, 2003.
Published: (2003)

Direct to consumer advertising (DTC) : hearing before the Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, first session, July 24, 2001.
Published: (2004)

Prescription drugs : trends in FDA's oversight of direct-to-consumer advertising : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /
by: Crosse, Marcia
Published: (2008)

Potential effects of a ban on direct-to-consumer advertising of new prescription drugs.
by: Campbell, Sheila (Sheila Marie)
Published: (2011)

Direct-to-consumer advertising of prescription drugs : what are the consequences? : hearing before the Special Committee on Aging, United States Senate, One Hundred Eighth Congress, first session, Washington, DC, July 22, 2003.
Published: (2003)

Prescription drug advertising to consumers : staff report /
Published: (1984)

Drug shortages : causes, FDA authority, and policy options /
by: Dabrowska, Agata
Published: (2018)

Prescription drugs : FDA oversight of direct-to-consumer advertising has limitations.
Published: (2002)

60 minutes.
Published: (2004)

Comparison of reimbursement prices for multiple-source prescription drugs in the United States and Canada.
Published: (1991)

Improving drug pricing transparency and lowering prices for American consumers : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 21, 2019.
Published: (2021)

Big bucks, big pharma : marketing disease & pushing drugs /
Published: (2006)

Comparative pricing of prescription drugs sold in the United States and Canada and the effects on U.S. customers [as printed] : hearing before the Subcommittee on Consumer Affairs, Foreign Commerce and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, first session, September 5, 2001.
Published: (2003)

Internet pharmacy and drug importation : exploring risks and benefits : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, first session, Washington, DC, January 26, 2005.
Published: (2005)

Internet pharmacy and drug importation : exploring risks and benefits : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, first session, Washington, DC, January 26, 2005.
Published: (2005)

The new handbook of prescription drugs: official names, prices, and sources for patient and doctor.
by: Burack, Richard
Published: (1970)

Sales, promotion, and product differentiation in two prescription drug markets /
by: Bond, Ronald S., et al.

Prices for brand-name drugs under selected federal programs.
by: Somers, Julie A. (Julie Ann), 1971-
Published: (2005)

Guide to prescription drug costs /
Published: (1980)

Prescription drug prices : are we getting our money's worth? : a majority staff report of the Special Committee on Aging, United States Senate.
Published: (1989)

Prices for brand-name drugs under selected federal programs.
by: Somers, Julie A. (Julie Ann), 1971-
Published: (2005)

Advertisement. : As there is hardly any thing of this world more deservingly welcome to mankinde, than health and long life ...
by: Bromfield, M.
Published: (1680)

The effects of escalating drug costs on the elderly : hearing before the Special Committee on Aging, United States Senate, One Hundred Second Congress, second session : morning session, Macon, GA, April 22, 1992; afternoon session, Atlanta, GA, April 22, 1992.
Published: (1992)

Prescription drug price inflation : are prices rising too fast? : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, December 8, 2009.
Published: (2012)

Options for safe and effective prescription drug importation : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Eighth Congress, second session, March 11, 2004.
Published: (2012)

Examining prescription drug importation : a review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002.
Published: (2002)

Big bucks, big pharma : marketing disease & pushing drugs /
Published: (2014)

An advertisement of concern to the city and nati[on]. : These are to signifie, that the famous and most approved lozenges, made by John Piercy, Gent. whose ability and skill is so well known, for these 27. years and upwards ...
by: Piercy, John, fl. 1665
Published: (1665)

Why are some generic drugs skyrocketing in price? : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014.
Published: (2017)

Medicare-endorsed prescription drug discount card : their impact on small business : hearing before the Committee on Small Business, House of Representatives, One Hundred Seventh Congress, first session, Washington, DC, October 25, 2001.
Published: (2002)

Drug safety and pricing : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... June 13, 2000.
Published: (2000)

Looks can be deceiving : the medicine you buy from outside the United States may be unsafe or ineffective.
Published: (2004)

Las apariencias engañan : la medicina que usted compra fuera de los Estados Unidos puede ser peligrosa y deficiente.
Published: (2004)

Emerging health care issues : follow-on biologic drug competition.
Published: (2009)